Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Initiates Coverage On Allbirds with Neutral Rating

BTIG Initiates Coverage On Allbirds with Neutral Rating

BTIG analyst Janine Stichter initiates coverage on Allbirds (NASDAQ:BIRD) with a Neutral rating.

byBenzinga Newsdesk

February 7, 2023

1 minute read

BTIG analyst Janine Stichter initiates coverage on Allbirds (NASDAQ:BIRD) with a Neutral rating.

Raymond James Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $18

By Benzinga Newsdesk

October 5, 7:43 AM

Raymond James analyst Robert Dodd maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20.5 to $18.

CCAP

Media
News

Uber And Lyft NYC Drivers Likely To Get A Pay Boost

By Anusuya Lahiri

November 16, 7:23 AM

Uber Technologies, Inc (NYSE:UBER) and Lyft, Inc (NASDAQ:LYFT) will have to increase the minimum pay rates for drivers in New York…

LYFT

Analyst Ratings

Where Vir Biotechnology Stands With Analysts

By Benzinga Insights

July 21, 9:00 AM

Within the last quarter, Vir Biotechnology (NASDAQ:VIR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

VIR

Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit

By Vandana Singh

February 8, 1:51 PM

Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments.

BAX

BTIG Initiates Coverage On Allbirds with Neutral Rating

Related Posts

Raymond James Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $18

Uber And Lyft NYC Drivers Likely To Get A Pay Boost

Where Vir Biotechnology Stands With Analysts

Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit